Skip to main content

Featured

Enterprise backs outreach jab service

Secretary for the Civil Service Patrick Nip visited AIA Hong Kong & Macau today to view the administering of the BioNTech vaccine to about 400 people as arranged by the Government's outreach vaccination service.   Mr Nip said it is encouraging that various enterprises have joined the Government in promoting the Early Vaccination for All campaign and called on their employees to receive vaccination.   He hopes that vaccinated citizens will also encourage their family members and friends to get the jab to help build an immune barrier in Hong Kong.   The outreach vaccination programme has received enthusiastic support since its launch, with vaccination services provided for the Hong Kong Sports Institute, global professional services enterprises, property developers, financial institutions and more. http://dlvr.it/S4y8xb

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqJtL

Popular Posts